Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Dermatologic 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vitamin A × Thoracic × Clear all
NCT03870529 2024-01-09

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
20 enrolled 6 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00712647 2012-09-26

CARET

Fred Hutchinson Cancer Center

Phase 4 Completed
18,314 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡